Marksans Pharma informs about press release

10 Mar 2023 Evaluate
Marksans Pharma has informed that it enclosed press release titled - Marksans Pharma announces US FDA approval for Famotidine Tablets USP, 10 mg and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

163.10 -6.85 (-4.03%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×